2WHO/NHLBI Workshop Report. Global initiative for asthma management and prevention: pocket guide for asthma management and prevention in children. Maryland: National Institute of Health, National Heart, Lung, and Blood Institute, 2002. 6-9. 被引量：1
3Hogg JC,James AL,Pare PD. Evidence for inflammation in asthma. Am Rev Respir Dis, 1991,143:S39-S42. 被引量：1
4Adams N,Bestall J,Jone PW. Inhaled fluticasone at different doses for chronic asthma. Cochrane Database Syst Rev,2002,(1):CD003534. 被引量：1
5Adams N,Bestall J,Jones PW. Inhaled fluticasone proprionate for chronic asthma. Cochrane Database Syst Rev,2001,(3):CD003135. 被引量：1
6Kamada AK, Szefler SJ, Martin KJ, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med, 1996,153(6 Pt 1):1739-1748. 被引量：1
7Pauwels RA, Pedrson S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet, 2003, 361:1071-1076. 被引量：1
8Clark DJ, Grove A, Cargill RI, et al. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax, 1996, 51:262-266. 被引量：1
